{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:43:28Z","timestamp":1783349008441,"version":"3.54.6"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["A\/2\u201311\/1-2012-0001"],"award-info":[{"award-number":["A\/2\u201311\/1-2012-0001"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["EFOP-3.6.2-16-2017-00006"],"award-info":[{"award-number":["EFOP-3.6.2-16-2017-00006"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00015"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00015"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009232","name":"Debreceni Egyetem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Magyar Tudom\u00e1nyos Akad\u00e9mia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.abb.2019.01.031","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T10:59:18Z","timestamp":1548845958000},"page":"82-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout"],"prefix":"10.1016","volume":"670","author":[{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Szamosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerg\u0151 E.","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elek","family":"Kocsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Benk\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresrev.2008.12.020","article-title":"Role of interleukin-1beta during pain and inflammation","volume":"60","author":"Ren","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.abb.2019.01.031_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1096\/fasebj.2.2.3277884","article-title":"Biology of interleukin 1","volume":"2","author":"Dinarello","year":"1988","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.abb.2019.01.031_bib3","doi-asserted-by":"crossref","first-page":"a016287","DOI":"10.1101\/cshperspect.a016287","article-title":"Inflammasomes","volume":"6","author":"de Zoete","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/08830185.2017.1397656","article-title":"TLRs\/NLRs: shaping the landscape of host immunity","volume":"37","author":"Dolasia","year":"2018","journal-title":"Int. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.gene.2004.05.002","article-title":"Structural, expression, and evolutionary analysis of mouse CIAS1","volume":"338","author":"Anderson","year":"2004","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.abb.2019.01.031_bib6","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4049\/jimmunol.1002720","article-title":"Differential expression of NLRP3 among hematopoietic cells","volume":"186","author":"Guarda","year":"2011","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.abb.2019.01.031_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/intimm\/dxq058","article-title":"Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice","volume":"22","author":"Lech","year":"2010","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.abb.2019.01.031_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1369\/jhc.6A7101.2006","article-title":"Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response","volume":"55","author":"Kummer","year":"2007","journal-title":"J. Histochem. Cytochem."},{"issue":"4","key":"10.1016\/j.abb.2019.01.031_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1beta secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/cdd.2011.159","article-title":"The inflammasome: in memory of Dr. Jurg Tschopp","volume":"19","author":"Dagenais","year":"2012","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.abb.2019.01.031_bib11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/imm.12052","article-title":"Ragweed pollen extract intensifies lipopolysaccharide-induced priming of NLRP3 inflammasome in human macrophages","volume":"138","author":"Varga","year":"2013","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.abb.2019.01.031_bib12","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.abb.2019.01.031_bib13","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1189\/jlb.3A0716-300RR","article-title":"Different dynamics of NLRP3 inflammasome-mediated IL1beta production in GM-CSF- and M-CSF-differentiated human macrophages","volume":"101","author":"Budai","year":"2017","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/eji.200940185","article-title":"Critical functions of priming and lysosomal damage for NLRP3 activation","volume":"40","author":"Hornung","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.abb.2019.01.031_bib15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1177\/002215540104901009","article-title":"Expression of apoptosis-associated speck-like protein containing a caspase recruitment domain, a pyrin N-terminal homology domain-containing protein, in normal human tissues","volume":"49","author":"Masumoto","year":"2001","journal-title":"J. Histochem. Cytochem."},{"issue":"10","key":"10.1016\/j.abb.2019.01.031_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139416","article-title":"Mitochondrial ROS induces cardiac inflammation via a pathway through mtDNA damage in a pneumonia-related sepsis model","volume":"10","author":"Yao","year":"2015","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.abb.2019.01.031_bib17","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1111\/febs.13379","article-title":"Role of the nucleotide-binding domain-like receptor protein 3 inflammasome in acute kidney injury","volume":"282","author":"Cao","year":"2015","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.abb.2019.01.031_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ni1459","article-title":"A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses","volume":"8","author":"Mayor","year":"2007","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.abb.2019.01.031_bib19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.abb.2019.01.031_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coi.2017.10.011","article-title":"Recent advances in inflammasome biology","volume":"50","author":"Place","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.abb.2019.01.031_bib21","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1038\/ncomms8360","article-title":"Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury","volume":"6","author":"Ito","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ni.3333","article-title":"NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component","volume":"17","author":"Shi","year":"2016","journal-title":"Nat. Immunol."},{"issue":"7590","key":"10.1016\/j.abb.2019.01.031_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature16959","article-title":"NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1074\/jbc.C115.700492","article-title":"A genome-wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation","volume":"291","author":"Schmid-Burgk","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.abb.2019.01.031_bib25","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/sj.cdd.4402195","article-title":"Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration","volume":"14","author":"Petrilli","year":"2007","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.abb.2019.01.031_bib26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.immuni.2016.08.010","article-title":"K(+) efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria","volume":"45","author":"Gross","year":"2016","journal-title":"Immunity"},{"issue":"28","key":"10.1016\/j.abb.2019.01.031_bib27","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.1117765109","article-title":"Critical role for calcium mobilization in activation of the NLRP3 inflammasome","volume":"109","author":"Murakami","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.immuni.2012.06.013","article-title":"Cell volume regulation modulates NLRP3 inflammasome activation","volume":"37","author":"Compan","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41467-017-00227-x","article-title":"CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation","volume":"8","author":"Tang","year":"2017","journal-title":"Nat. Commun."},{"issue":"40","key":"10.1016\/j.abb.2019.01.031_bib30","doi-asserted-by":"crossref","first-page":"E9371","DOI":"10.1073\/pnas.1812744115","article-title":"Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming","volume":"115","author":"Green","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.abb.2019.01.031_bib31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/ni.2595","article-title":"Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function","volume":"14","author":"Sokolovska","year":"2013","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.abb.2019.01.031_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3801","article-title":"Cellular mechanisms and physiological consequences of redox-dependent signalling","volume":"15","author":"Holmstrom","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.abb.2019.01.031_bib33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/1753425913508593","article-title":"Endoplasmic reticulum stress is sufficient for the induction of IL-1beta production via activation of the NF-kappaB and inflammasome pathways","volume":"20","author":"Kim","year":"2014","journal-title":"Innate Immun."},{"issue":"2","key":"10.1016\/j.abb.2019.01.031_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.immuni.2013.08.001","article-title":"Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation","volume":"39","author":"Iyer","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.abb.2019.01.031_bib36","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ni.3030","article-title":"The RIP1-RIP3 complex initiates mitochondrial fission to fuel NLRP3","volume":"15","author":"Rayamajhi","year":"2014","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.abb.2019.01.031_bib37","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ni.3015","article-title":"RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway","volume":"15","author":"Wang","year":"2014","journal-title":"Nat. Immunol."},{"issue":"7329","key":"10.1016\/j.abb.2019.01.031_bib38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.abb.2019.01.031_bib39","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.bbamcr.2014.03.009","article-title":"New functions of mitochondria associated membranes in cellular signaling","volume":"1843","author":"van Vliet","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"6296","key":"10.1016\/j.abb.2019.01.031_bib40","doi-asserted-by":"crossref","first-page":"aaf5549","DOI":"10.1126\/science.aaf5549","article-title":"ER-mitochondria contacts couple mtDNA synthesis with mitochondrial division in human cells","volume":"353","author":"Lewis","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41419-017-0027-2","article-title":"Mitochondria-associated membranes (MAMs) and inflammation","volume":"9","author":"Missiroli","year":"2018","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.abb.2019.01.031_bib42","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ni.2550","article-title":"Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome","volume":"14","author":"Misawa","year":"2013","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.abb.2019.01.031_bib43","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1084\/jem.20162040","article-title":"Protein kinase D at the Golgi controls NLRP3 inflammasome activation","volume":"214","author":"Zhang","year":"2017","journal-title":"J. Exp. Med."},{"issue":"7444","key":"10.1016\/j.abb.2019.01.031_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.celrep.2015.05.046","article-title":"mTORC1-Induced HK1-dependent glycolysis regulates NLRP3 inflammasome activation","volume":"12","author":"Moon","year":"2015","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12608","article-title":"Metabolic regulation of NLRP3","volume":"281","author":"Hughes","year":"2018","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.abb.2019.01.031_bib47","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.abb.2019.01.031_bib48","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4049\/jimmunol.1500509","article-title":"Multiple cathepsins promote pro-IL-1beta synthesis and NLRP3-mediated IL-1beta activation","volume":"195","author":"Orlowski","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib49","doi-asserted-by":"crossref","first-page":"C83","DOI":"10.1152\/ajpcell.00298.2015","article-title":"NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx","volume":"311","author":"Katsnelson","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.abb.2019.01.031_bib50","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3389\/fimmu.2018.01054","article-title":"Posttranslational regulation of the NLR family pyrin domain-containing 3 inflammasome","volume":"9","author":"Shim","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.abb.2019.01.031_bib51","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1172\/JCI83669","article-title":"NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22","volume":"126","author":"Spalinger","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.abb.2019.01.031_bib52","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.20160933","article-title":"NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain","volume":"214","author":"Stutz","year":"2017","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.abb.2019.01.031_bib53","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ni.3538","article-title":"NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations","volume":"17","author":"Mortimer","year":"2016","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.abb.2019.01.031_bib54","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2017.08.017","article-title":"NLRP3 phosphorylation is an essential priming event for inflammasome activation","volume":"68","author":"Song","year":"2017","journal-title":"Mol. Cell"},{"issue":"1\u20132","key":"10.1016\/j.abb.2019.01.031_bib56","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.abb.2019.01.031_bib57","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.4049\/jimmunol.1700184","article-title":"ARIH2 ubiquitinates NLRP3 and negatively regulates NLRP3 inflammasome activation in macrophages","volume":"199","author":"Kawashima","year":"2017","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ni.2474","article-title":"Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1beta","volume":"14","author":"Mishra","year":"2013","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.abb.2019.01.031_bib59","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1074\/jbc.M113.515080","article-title":"3,4-methylenedioxy-beta-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome","volume":"289","author":"He","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib60","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1038\/s41467-018-05321-2","article-title":"SUMO-mediated regulation of NLRP3 modulates inflammasome activity","volume":"9","author":"Barry","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.abb.2019.01.031_bib61","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1084\/jem.20132486","article-title":"The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation","volume":"211","author":"Rodgers","year":"2014","journal-title":"J. Exp. Med."},{"issue":"22","key":"10.1016\/j.abb.2019.01.031_bib62","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1016\/j.jmb.2017.10.001","article-title":"Ubiquitin-modifying enzymes and regulation of the inflammasome","volume":"429","author":"Kattah","year":"2017","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib63","doi-asserted-by":"crossref","first-page":"15020","DOI":"10.1038\/s41598-017-15314-8","article-title":"BOT-4-one attenuates NLRP3 inflammasome activation: NLRP3 alkylation leading to the regulation of its ATPase activity and ubiquitination","volume":"7","author":"Shim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2019.01.031_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2016.03.002","article-title":"Shaping the spectrum - from autoinflammation to autoimmunity","volume":"165","author":"Hedrich","year":"2016","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.abb.2019.01.031_bib65","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med."},{"issue":"11","key":"10.1016\/j.abb.2019.01.031_bib66","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10055","key":"10.1016\/j.abb.2019.01.031_bib67","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","article-title":"Gout","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrrheum.2012.143","article-title":"Uric acid as a danger signal in gout and its comorbidities","volume":"9","author":"Rock","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jbspin.2015.01.002","article-title":"Hyperuricemia starts at 360 micromoles (6 mg\/dL)","volume":"82","author":"Bardin","year":"2015","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.abb.2019.01.031_bib70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0950-3579(05)80197-9","article-title":"Crystal arthritis","volume":"9","author":"Poor","year":"1995","journal-title":"Bailliere\u2019s Clin. Rheumatol."},{"key":"10.1016\/j.abb.2019.01.031_bib71","series-title":"Textbook on rheumatic diseases (Bijlsma JWJ, da Silva JAP","first-page":"301","article-title":"Crystal arthropathies","author":"Pascual","year":"2012"},{"key":"10.1016\/j.abb.2019.01.031_bib72","series-title":"Gout and Other Crystal Diseases","author":"Szekanecz","year":"2014"},{"key":"10.1016\/j.abb.2019.01.031_bib73","doi-asserted-by":"crossref","unstructured":"Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, Yang XF: Uric acid, hyperuricemia and vascular diseases. Front. Biosci., 17:656-669.","DOI":"10.2741\/3950"},{"issue":"7","key":"10.1016\/j.abb.2019.01.031_bib74","first-page":"529","article-title":"Pro-inflammatory cytokines in atherosclerosis","volume":"10","author":"Szekanecz","year":"2008","journal-title":"Isr. Med. Assoc. J."},{"issue":"2","key":"10.1016\/j.abb.2019.01.031_bib75","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/ar2952","article-title":"Mechanisms of inflammation in gout","volume":"12","author":"Busso","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"6957","key":"10.1016\/j.abb.2019.01.031_bib76","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.abb.2019.01.031_bib77","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrrheum.2016.61","article-title":"Toll-like receptors and chronic inflammation in rheumatic diseases: new developments","volume":"12","author":"Joosten","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"8","key":"10.1016\/j.abb.2019.01.031_bib78","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1172\/JCI28075","article-title":"MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals","volume":"116","author":"Chen","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.abb.2019.01.031_bib79","doi-asserted-by":"crossref","first-page":"10274","DOI":"10.1038\/ncomms10274","article-title":"Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis","volume":"7","author":"Mulay","year":"2016","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.abb.2019.01.031_bib80","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7081","key":"10.1016\/j.abb.2019.01.031_bib81","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.abb.2019.01.031_bib82","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.21238","article-title":"Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation","volume":"52","author":"Liu-Bryan","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.abb.2019.01.031_bib83","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/art.27667","article-title":"Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis","volume":"62","author":"Joosten","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.abb.2019.01.031_bib84","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/art.33355","article-title":"NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout","volume":"64","author":"Amaral","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib85","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.immuni.2012.01.018","article-title":"Tschopp J: inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1","volume":"36","author":"Gross","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib86","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrrheum.2016.166","article-title":"Interleukin-1 function and role in rheumatic disease","volume":"12","author":"Schett","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cyto.2005.11.010","article-title":"Plasma interleukin (IL)-18 (interferon-gamma-inducing factor) and other inflammatory cytokines in patients with gouty arthritis and monosodium urate monohydrate crystal-induced secretion of IL-18","volume":"33","author":"Inokuchi","year":"2006","journal-title":"Cytokine"},{"issue":"Suppl 3","key":"10.1016\/j.abb.2019.01.031_bib88","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1186\/ar562","article-title":"Interactions between leukocytes and endothelial cells in gout: lessons from a self-limiting inflammatory response","volume":"4","author":"Haskard","year":"2002","journal-title":"Arthritis Res."},{"issue":"11","key":"10.1016\/j.abb.2019.01.031_bib89","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1136\/ard.2010.128454","article-title":"The pathogenesis of bone erosions in gouty arthritis","volume":"69","author":"Schlesinger","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.abb.2019.01.031_bib90","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2013.61","article-title":"Targeting inflammasomes in rheumatic diseases","volume":"9","author":"So","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.abb.2019.01.031_bib91","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/annrheumdis-2014-206564","article-title":"Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra","volume":"75","author":"Crisan","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/icb.2009.89","article-title":"Innate inflammation and resolution in acute gout","volume":"88","author":"Martin","year":"2010","journal-title":"Immunol. Cell Biol."},{"issue":"Suppl 1","key":"10.1016\/j.abb.2019.01.031_bib93","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000046","article-title":"Why does the gout attack stop? A roadmap for the immune pathogenesis of gout","volume":"1","author":"Schett","year":"2015","journal-title":"RMD open"},{"issue":"7","key":"10.1016\/j.abb.2019.01.031_bib94","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00109-015-1295-x","article-title":"How neutrophil extracellular traps orchestrate the local immune response in gout","volume":"93","author":"Maueroder","year":"2015","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib95","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/eji.201545605","article-title":"PMA and crystal-induced neutrophil extracellular trap formation involves RIPK1-RIPK3-MLKL signaling","volume":"46","author":"Desai","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.abb.2019.01.031_bib96","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.abb.2019.01.031_bib97","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.1780390718","article-title":"Inhibition and prevention of monosodium urate monohydrate crystal-induced acute inflammation in vivo by transforming growth factor beta1","volume":"39","author":"Liote","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.abb.2019.01.031_bib98","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1136\/ard.2010.145821","article-title":"Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGFbeta1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3","volume":"70","author":"Chen","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.abb.2019.01.031_bib99","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/annrheumdis-2014-206966","article-title":"Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1beta and by the induction of endogenous IL-1Ra","volume":"75","author":"Joosten","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.abb.2019.01.031_bib100","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1136\/ard.2008.096693","article-title":"Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007","volume":"68","author":"Elliot","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.abb.2019.01.031_bib101","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","article-title":"Synovial fluid analysis for diagnosis of intercritical gout","volume":"131","author":"Pascual","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.abb.2019.01.031_bib102","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/annrheumdis-2011-201215","article-title":"Purine-rich foods intake and recurrent gout attacks","volume":"71","author":"Zhang","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.abb.2019.01.031_bib103","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/annrheumdis-2016-209467","article-title":"Treat-to-target (T2T) recommendations for gout","volume":"76","author":"Kiltz","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib104","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"Updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.abb.2019.01.031_bib105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/BOR.0b013e3282f524a2","article-title":"Lifestyle and gout","volume":"20","author":"Hak","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.abb.2019.01.031_bib106","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e328335ef38","article-title":"A prescription for lifestyle change in patients with hyperuricemia and gout","volume":"22","author":"Choi","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.abb.2019.01.031_bib107","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/annrheumdis-2013-203325","article-title":"Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative","volume":"73","author":"Sivera","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.abb.2019.01.031_bib108","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.39107","article-title":"A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout","volume":"67","author":"Vieira","year":"2015","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib109","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1189\/jlb.3A1015-453RRR","article-title":"Dietary fiber and the short-chain fatty acid acetate promote resolution of neutrophilic inflammation in a model of gout in mice","volume":"101","author":"Vieira","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.abb.2019.01.031_bib110","doi-asserted-by":"crossref","first-page":"20602","DOI":"10.1038\/srep20602","article-title":"Intestinal microbiota distinguish gout patients from healthy humans","volume":"6","author":"Guo","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.abb.2019.01.031_bib111","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","article-title":"Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation","volume":"38","author":"Yan","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib112","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/art.33412","article-title":"Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: results of a phase II randomized, double-blind, placebo-controlled trial","volume":"64","author":"Schumacher","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.abb.2019.01.031_bib113","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1136\/ard.2009.108936","article-title":"The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study","volume":"68","author":"Terkeltaub","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.abb.2019.01.031_bib114","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/ket114","article-title":"Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial","volume":"52","author":"Mitha","year":"2013","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.abb.2019.01.031_bib115","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.abb.2019.01.031_bib116","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10067-014-2601-7","article-title":"Anakinra treatment in patients with gout and type 2 diabetes","volume":"34","author":"Vitale","year":"2015","journal-title":"Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.abb.2019.01.031_bib117","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1136\/ard.2007.073759","article-title":"Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra","volume":"66","author":"McGonagle","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.abb.2019.01.031_bib118","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","article-title":"Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions","volume":"71","author":"Schlesinger","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.abb.2019.01.031_bib119","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1002\/art.27600","article-title":"Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study","volume":"62","author":"So","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.abb.2019.01.031_bib120","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/ard.2010.144063","article-title":"Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study","volume":"70","author":"Schlesinger","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.abb.2019.01.031_bib121","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","article-title":"Treating inflammation by blocking interleukin-1 in humans","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin. Immunol."},{"issue":"8","key":"10.1016\/j.abb.2019.01.031_bib122","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib123","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.abb.2019.01.031_bib124","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1196\/annals.1422.036","article-title":"Accelerated atherosclerosis in rheumatoid arthritis","volume":"1108","author":"Szekanecz","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.abb.2019.01.031_bib125","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/CIRCRESAHA.118.311362","article-title":"NLRP3 inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.abb.2019.01.031_bib126","first-page":"179","article-title":"Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells","volume":"124","author":"Libby","year":"1986","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.abb.2019.01.031_bib127","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.abb.2019.01.031_bib128","doi-asserted-by":"crossref","first-page":"5460302","DOI":"10.1155\/2016\/5460302","article-title":"Natural compounds as regulators of NLRP3 inflammasome-mediated IL-1beta production","volume":"2016","author":"Tozser","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"16","key":"10.1016\/j.abb.2019.01.031_bib129","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2174\/0929867324666170227121619","article-title":"Therapeutic targeting of NLRP3 inflammasomes by natural products and pharmaceuticals: a novel mechanistic approach for inflammatory diseases","volume":"24","author":"Jahan","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.abb.2019.01.031_bib130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/jpet.106.111344","volume":"321","author":"Wannamaker","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib131","first-page":"111","article-title":"Effects and mechanisms of potent caspase-1 inhibitor VX765 treatment on collagen-induced arthritis in mice","volume":"34","author":"Zhang","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"issue":"12","key":"10.1016\/j.abb.2019.01.031_bib132","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/art.25006","article-title":"Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta","volume":"60","author":"Joosten","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.abb.2019.01.031_bib133","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1038\/ncomms7555","article-title":"Xanthine oxidoreductase regulates macrophage IL1beta secretion upon NLRP3 inflammasome activation","volume":"6","author":"Ives","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib134","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.abb.2019.01.031_bib135","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.celrep.2017.02.004","article-title":"Beta-hydroxybutyrate deactivates neutrophil NLRP3 inflammasome to relieve gout flares","volume":"18","author":"Goldberg","year":"2017","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib136","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10753-015-0271-5","article-title":"Rebamipide suppresses monosodium urate crystal-induced interleukin-1beta production through regulation of oxidative stress and caspase-1 in THP-1 cells","volume":"39","author":"Kim","year":"2016","journal-title":"Inflammation"},{"issue":"8","key":"10.1016\/j.abb.2019.01.031_bib137","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/art.22023","article-title":"Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts","volume":"54","author":"Ahmed","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib138","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1189\/jlb.3A0514-261RR","article-title":"Epigallocatechin-3-gallate ameliorates autoimmune arthritis by reciprocal regulation of T helper-17 regulatory T cells and inhibition of osteoclastogenesis by inhibiting STAT3 signaling","volume":"100","author":"Lee","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152518","article-title":"Long-term effects of (-)-Epigallocatechin gallate (EGCG) on pristane-induced arthritis (PIA) in female dark Agouti rats","volume":"11","author":"Leichsenring","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.abb.2019.01.031_bib140","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/mnfr.201600106","article-title":"Epigallocatechin gallate inhibits urate crystals-induced peritoneal inflammation in C57BL\/6 mice","volume":"60","author":"Jhang","year":"2016","journal-title":"Mol. Nutr. Food Res."},{"issue":"6D","key":"10.1016\/j.abb.2019.01.031_bib141","first-page":"4381","article-title":"Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis)","volume":"17","author":"Aucamp","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/j.abb.2019.01.031_bib142","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2016.06.005","article-title":"A dietary bioflavonol suppresses monosodium urate crystal-induced inflammation in an animal model of acute gouty arthritis with reference to NLRP3 inflammasome, hypo-xanthine phospho-ribosyl transferase, and inflammatory mediators","volume":"786","author":"Dhanasekar","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.abb.2019.01.031_bib143","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1007\/s10753-014-9930-1","article-title":"The effects of morin on lipopolysaccharide-induced acute lung injury by suppressing the lung NLRP3 inflammasome","volume":"37","author":"Tianzhu","year":"2014","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.abb.2019.01.031_bib144","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1017\/S0007114515005310","article-title":"Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial","volume":"115","author":"Shi","year":"2016","journal-title":"Br. J. Nutr."},{"issue":"1","key":"10.1016\/j.abb.2019.01.031_bib145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jep.2004.03.037","article-title":"Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver","volume":"93","author":"Zhu","year":"2004","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.abb.2019.01.031_bib146","doi-asserted-by":"crossref","DOI":"10.1007\/s10787-017-0356-x","article-title":"Quercetin inhibits gout arthritis in mice: induction of an opioid-dependent regulation of inflammasome","author":"Ruiz-Miyazawa","year":"2017","journal-title":"Inflammopharmacology"},{"issue":"8","key":"10.1016\/j.abb.2019.01.031_bib147","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.2042-7158.2012.01504.x","article-title":"Therapeutic properties of quercetin on monosodium urate crystal-induced inflammation in rat","volume":"64","author":"Huang","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib148","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.abb.2019.01.031_bib149","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.molmet.2018.02.001","article-title":"Evidence against a role for NLRP3-driven islet inflammation in db\/db mice","volume":"10","author":"Kammoun","year":"2018","journal-title":"Mole. Metabol."},{"issue":"6","key":"10.1016\/j.abb.2019.01.031_bib150","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.4049\/jimmunol.1600035","article-title":"Efficacy and pharmacology of the NLRP3 inflammasome inhibitor CP-456,773 (CRID3) in murine models of dermal and pulmonary inflammation","volume":"197","author":"Primiano","year":"2016","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.abb.2019.01.031_bib151","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.kint.2016.03.035","article-title":"An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice","volume":"90","author":"Ludwig-Portugall","year":"2016","journal-title":"Kidney Int."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986118307550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986118307550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:08:50Z","timestamp":1757743730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986118307550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":151,"alternative-id":["S0003986118307550"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2019.01.031","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2019.01.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}